Biomea Fusion Inc Sustainability Reports
Biomea Fusion, Inc. is a clinical-stage biopharmaceutical enterprise specializing in the discovery and development of oral covalent small molecules. The company focuses on developing medicines for metabolic disorders, prioritizing solutions for insulin-deficient patients and combination treatments for diabetes and obesity.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00YS4WDD8
3 reports from 2021 to 2025
Company Profile
Biomea Fusion, Inc. is a clinical-stage biopharmaceutical enterprise specializing in the discovery and development of oral covalent small molecules. The company focuses on developing medicines for metabolic disorders, prioritizing solutions for insulin-deficient patients and combination treatments for diabetes and obesity.
Reports
3 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
